Project: Ghana Emergency Medicine Collaborative Document Title: Anaphylaxis Author(s): Peter Moyer (Boston University), MD, MPH 2012 License: Unless otherwise.

Slides:



Advertisements
Similar presentations
Author(s): Don M. Blumenthal, 2010 License: Unless otherwise noted, this material is made available under the terms of the Attribution – Non-commercial.
Advertisements

Author(s): Paul Conway, License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Michael Hortsch, Ph.D., 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Michael Hortsch, Ph.D., 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Caroline Richardson, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Noncommercial–Share.
Author(s): John Doe, MD; Jane Doe, PhD, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): John Doe, MD; Jane Doe, PhD, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Templates for editing U-M OER Materials
Author(s): Paul Conway, License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Module: Leadership Training Workshop for Health Professionals Organization: East Africa HEALTH Alliance Author(s): Dr. Roy William Mayega, Resource.
Author: Jonathan Trobe, MD, 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution 3.0.
Author(s): Seetha Monrad, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Noncommercial–Share.
Project: Ghana Emergency Medicine Collaborative Document Title: Open Educational Resources Author(s): University of Michigan Department of Emergency Medicine.
Module: Public Health Disaster Planning for Districts Organization: East Africa HEALTH Alliance, Author(s): Dr. Roy William Mayega (Makerere.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author: Michael Jibson, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Share.
Author(s): MELO 3D Project Team, 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Module: Leadership Training Workshop for Health Professionals Organization: East Africa HEALTH Alliance Author(s): Prof. William Bazeyo, Resource.
Author(s): MELO 3D Project Team, 2011 License: This work is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License. To view a.
Project: Ghana Emergency Medicine Collaborative Document Title: Approach to Acute Chest Pain Author(s): Rockefeller Oteng (University of Michigan), MD.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Joan Durrance, 2009 License: Unless otherwise noted, this material is made available under the terms of the Attribution - Non-commercial 3.0.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Project: Ghana Emergency Medicine Collaborative Document Title: Seizures Author(s): Ryan LaFollette, MD (University of Cincinnati), 2013 License: Unless.
Author(s): Gerald Abrams, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author: Michael Jibson, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Share.
Author(s): Kate Saylor, 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Gerald Abrams, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author: John Williams, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Project: Ghana Emergency Medicine Collaborative Document Title: My Bougie and Me Author(s): Vijay Kairam (University of Utah), MD 2012 License: Unless.
Author(s): Gerald Abrams, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author: Michael Jibson, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Share.
Author(s): Michael Hortsch, Ph.D., 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Michael Hortsch, Ph.D., 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Michael Hortsch, Ph.D., 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Brenda Gunderson, Ph.D., 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author: Michael Jibson, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Share.
We have reviewed this material in accordance with U.S. Copyright Law and have tried to maximize your ability to use, share, and adapt it. The citation.
Author: Michael Jibson, M.D., Ph.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Share.
Author(s): Michael Hortsch, Ph.D., 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Don M. Blumenthal, 2010 License: Unless otherwise noted, this material is made available under the terms of the Attribution – Non-commercial.
Author(s): MELO 3D Project Team, 2011 License: This work is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License. To view a.
Author(s): Don M. Blumenthal, 2010 License: Unless otherwise noted, this material is made available under the terms of the Attribution – Non-commercial.
Author(s): Steve Jackson, 2009 License: Unless otherwise noted, this material is made available under the terms of the Attribution - Noncommercial - Share.
Author(s): Lisa McLaughlin, 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution-ShareAlike.
Author(s): Gabriel Krieshok, Alex Pompe, 2011 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons.
Author(s): MELO 3D Project Team, 2011 License: This work is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License. To view a.
Author(s): MELO 3D Project Team, 2011 License: This work is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License. To view a.
Author(s): Gerald Abrams, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution–Non-commercial–Share.
Author(s): Paul Conway, PhD, 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
Author(s): Paul Conway, PhD, 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution.
1 Author(s): Andrew Rosenberg
Author: Michael Jibson, M.D., Ph.D., 2009
Author(s): John Doe, MD; Jane Doe, PhD, 2009
Author(s): Rajesh Mangrulkar, MD, 2009
Author(s): Paul Conway, PhD, 2010
Author: Robert Lyons, Ph.D., 2008
Author: Michael Jibson, M.D., Ph.D., 2009
Attribution: University of Michigan Medical School, Department of Internal Medicine License: Unless otherwise noted, this material is made available under.
1 Author(s): Rebecca W. Van Dyke, M.D., 2012
Author(s): Joan Durrance, 2009
1 Author(s): Rebecca W. Van Dyke, M.D., 2012
Attribution: University of Michigan Medical School, Department of Microbiology and Immunology License: Unless otherwise noted, this material is made available.
Attribution: Department of Neurology, 2009
Author(s): Neel Hajra, 2010 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution 3.0 License:
Author: Michael Jibson, M.D., Ph.D., 2009
Presentation transcript:

Project: Ghana Emergency Medicine Collaborative Document Title: Anaphylaxis Author(s): Peter Moyer (Boston University), MD, MPH 2012 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Share Alike-3.0 License: We have reviewed this material in accordance with U.S. Copyright Law and have tried to maximize your ability to use, share, and adapt it. These lectures have been modified in the process of making a publicly shareable version. The citation key on the following slide provides information about how you may share and adapt this material. Copyright holders of content included in this material should contact with any questions, corrections, or clarification regarding the use of content. For more information about how to cite these materials visit Any medical information in this material is intended to inform and educate and is not a tool for self-diagnosis or a replacement for medical evaluation, advice, diagnosis or treatment by a healthcare professional. Please speak to your physician if you have questions about your medical condition. Viewer discretion is advised: Some medical content is graphic and may not be suitable for all viewers. 1

Attribution Key for more information see: Use + Share + Adapt Make Your Own Assessment Creative Commons – Attribution License Creative Commons – Attribution Share Alike License Creative Commons – Attribution Noncommercial License Creative Commons – Attribution Noncommercial Share Alike License GNU – Free Documentation License Creative Commons – Zero Waiver Public Domain – Ineligible: Works that are ineligible for copyright protection in the U.S. (17 USC § 102(b)) *laws in your jurisdiction may differ Public Domain – Expired: Works that are no longer protected due to an expired copyright term. Public Domain – Government: Works that are produced by the U.S. Government. (17 USC § 105) Public Domain – Self Dedicated: Works that a copyright holder has dedicated to the public domain. Fair Use: Use of works that is determined to be Fair consistent with the U.S. Copyright Act. (17 USC § 107) *laws in your jurisdiction may differ Our determination DOES NOT mean that all uses of this 3rd-party content are Fair Uses and we DO NOT guarantee that your use of the content is Fair. To use this content you should do your own independent analysis to determine whether or not your use will be Fair. { Content the copyright holder, author, or law permits you to use, share and adapt. } { Content Open.Michigan believes can be used, shared, and adapted because it is ineligible for copyright. } { Content Open.Michigan has used under a Fair Use determination. } 2

Definition A rapid onset allergic reaction which may be life threatening True emergency – requires immediate diagnosis and Rx 3

Terminology Anaphylaxis - IgE mediated after previous exposure Anaphylactoid - not IgE but immune complex complement mediated; no prior exposure required Therapeutically identical 4

Common Causes Drugs b lactam antibiotics: penicillins and cephalosporins aspirin and other NSAIDs sulfa drugs aminoglycosides 5

Common Causes Foods and additives – more common in children shellfish nuts milk eggs sulfites wheat soybeans 6

Common Causes Stings Vaccines Latex X-Ray contrast material 7

Pathophysiology Release of vasoactive and bronchial mediators from mast cells and basophils (histamines, prostaglandins, leukotrienes, etc.) 8

Clinical Picture 2 or more of following: skin pruritus urticaria respiratory upper airway lump in throat hoarseness stridor lower airway bronchoconstriction wheezing 9

Clinical Picture Hypotension - distributive shock GI - cramps and vomiting 10

Clinical Picture Rapid onset - minutes to hours, most within 1 hour 11

Recurrence Up to 20% recur within 8 hours 12

Treatment 1st line: Epinephrine - has both alpha and beta-2 effects - reduces mucosal edema, reduces capillary leakage, vasoconstricts, bronchodilates 13

Treatment Epinephrine dosing and administration o 0.3 (kids) to 0.5 mg (adults); ( ml of 1:1000) IM in thigh o Repeat q 5 min as necessary o Epinephrine auto injector (Epipen) is easiest and safest (comes in 0.3 and 0.5 mg dosages) 14

Treatment Epinephrine – if refractory to IM Rx or cardiovascular collapse – 0.1 mg IV epi over minutes (0.1 mg of the 1:10,000) 15

Treatment Shock – IV fluids wide open 16

Treatment IV steroids and antihistamines (H1 and H2 blockers) to prevent recurrence 17

Observation Admit or observe for 8 hours to watch for recurrence 18